India, April 14 -- Drug major Johnson & Johnson (JNJ), while reporting sharply lower first-quarter profit despite sales growth, on Tuesday lifted fiscal 2026 earnings and sales forecast for fiscal 2026. The company also announced higher quarterly dividend.
In pre-market activity, the shares were losing around 1.6 percent, trading at $234.00.
Joaquin Duato, Chairman and Chief Executive Officer, said, "Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact."
For fiscal 2026, the company now projects adjusted earnings in a range of $11.45 to $11.65 per share, with $11.55 in mid-point, and adjusted operational earnings in a range of $11.30 to $11.50 per share, with $11.40 in ...